126 related articles for article (PubMed ID: 2297192)
1. The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome.
Parsons PE; Giclas PC
Am Rev Respir Dis; 1990 Jan; 141(1):98-103. PubMed ID: 2297192
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of plasma SC5b-9 (SMAC) in patients with ARDS].
Hara N; Abe M; Kawarada Y; Inuzuka S; Takahashi H; Goya T; Shigematsu N; Fujita T
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):796-801. PubMed ID: 1630043
[TBL] [Abstract][Full Text] [Related]
3. Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation.
Langlois PF; Gawryl MS; Zeller J; Lint T
Heart Lung; 1989 Jan; 18(1):71-84. PubMed ID: 2783581
[TBL] [Abstract][Full Text] [Related]
4. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
5. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
Langlois PF; Gawryl MS
Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
[TBL] [Abstract][Full Text] [Related]
6. [Changes in complement breakdown products and terminal complement complex in patients with acute glomerulonephritis].
Kojima H; Ohi H; Seki M; Hatano M
Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):925-31. PubMed ID: 2585834
[TBL] [Abstract][Full Text] [Related]
7. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
[TBL] [Abstract][Full Text] [Related]
8. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients.
Vallhonrat H; Williams WW; Cosimi AB; Tolkoff-Rubin N; Ginns LC; Wain JC; Preffer F; Olszak I; Wee S; Delmonico FL; Pascual M
Transplantation; 1999 Jan; 67(2):253-8. PubMed ID: 10075589
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
[TBL] [Abstract][Full Text] [Related]
10. The association of circulating endotoxin with the development of the adult respiratory distress syndrome.
Parsons PE; Worthen GS; Moore EE; Tate RM; Henson PM
Am Rev Respir Dis; 1989 Aug; 140(2):294-301. PubMed ID: 2764364
[TBL] [Abstract][Full Text] [Related]
11. Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis.
Brodeur JP; Ruddy S; Schwartz LB; Moxley G
Arthritis Rheum; 1991 Dec; 34(12):1531-7. PubMed ID: 1747138
[TBL] [Abstract][Full Text] [Related]
12. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
Gyongyossy-Issa MI; McLeod E; Devine DV
J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
[TBL] [Abstract][Full Text] [Related]
13. Complement activation in cancer patients undergoing immunotherapy with interleukin-2 (IL-2): binding of complement and C-reactive protein by IL-2-activated lymphocytes.
Vachino G; Gelfand JA; Atkins MB; Tamerius JD; Demchak P; Mier JW
Blood; 1991 Nov; 78(10):2505-13. PubMed ID: 1824247
[TBL] [Abstract][Full Text] [Related]
14. A flow cytometric immunoassay to quantify adsorption of complement activation products (iC3b, C3d, SC5b-9) on artificial surfaces.
Gemmell CH
J Biomed Mater Res; 1997 Dec; 37(4):474-80. PubMed ID: 9407295
[TBL] [Abstract][Full Text] [Related]
15. Complement activation occurs through both classical and alternative pathways prior to onset and resolution of adult respiratory distress syndrome.
Langlois PF; Gawryl MS
Clin Immunol Immunopathol; 1988 May; 47(2):152-63. PubMed ID: 2832113
[TBL] [Abstract][Full Text] [Related]
16. Complement components and their activation products in pleural fluid.
Salomaa ER; Viander M; Saaresranta T; Terho EO
Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of complement activation between tuberculous and malignant pleuritis].
Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
[TBL] [Abstract][Full Text] [Related]
18. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of detection of complement activation products in evaluating SLE activity.
Nagy G; Brózik M; Varga L; Füst G; Kirschfink M; Kiss E; Gergely P
Lupus; 2000; 9(1):19-25. PubMed ID: 10713643
[TBL] [Abstract][Full Text] [Related]
20. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
